A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315).
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315). — المؤلف: Geller, James I — Cancer 20190912
- المؤلف
- Geller, James I
- النشر
- Cancer 20190912
- الوصف
- 4548-4555 p.
- الموضوعات
- Administration, Oral؛ Adolescent؛ Axitinib؛ Child؛ Drug Administration Schedule؛ Female؛ Humans؛ Male